Cryosite Limited (ASX:CTE)

Cryosite Revenue

In the fiscal year ending June 30, 2026, Cryosite had annual revenue of 16.70M AUD with 18.31% growth. Cryosite had revenue of 8.43M in the half year ending June 30, 2026, with 35.70% growth. That makes Cryosite the 36,628th largest company in the world by revenue and 652nd in Australia.

• Revenue: 16.70M
• Revenue Growth: +18.31%
• P/S Ratio: 3.57
• Revenue / Employee: 618.52K
• Employees: 27
• Market Cap: 59.55M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Ambient, Cold, and Frozen 12.02M 72.0%
• Cord Blood 2.41M 14.4%
• Ultra-frozen and Cryogenic 2.28M 13.6%

Fiscal year ended Jun 30, 2026 See the full Cryosite breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	16.70M	2.58M	18.31%
Jun 30, 2025	14.12M	1.50M	11.93%
Jun 30, 2024	12.61M	677.00K	5.67%
Jun 30, 2023	11.94M	178.00K	1.51%
Jun 30, 2022	11.76M	1.73M	17.29%

Data Source: S&P Global Market Intelligence Last updated: Aug 18, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 26, 2026

Data Sources Report a data error